Medication

Pain control

The availability of a new opioid-based treatment option, has led pain specialists to believe they may at last be able to solve the age-old problem of how to provide effective chronic pain relief without causing opioid-induced constipation (OIC).

Doctors often ignore electronic drug safety alerts

When prescribing drugs electronically, US clinicians often over-ride automatic drug warning alerts in computer-based systems, according to a new study led by researchers at the Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Centre (BIDMC), Boston, published in the Archives of Internal Medicine (9/2/09).

Photo

Global economic crisis hits biotech and pharma firms

The current global financial crisis is like to hit Bio-tech and pharmaceutical companies due to a lack of funding for research and the discovery and production of many new drugs, according to Professor David Wield, Director of the Economic and Social Research Council's (ESRC) Edinburgh-based Innogen Centre, and chair of the recent international ESRC conference Genomics and Society: Reinventing…

Photo

UPS Healthcare Logistics

From 'A' as in Austria to 'Z' as in Zanzibar the letters 'UPS' (United Parcel Service) are known for express transportation and logistics services. Since the late '90s the UPS section responsible for logistics services has delivered supply chain solutions for healthcare customers, including pharmaceutical, biotech, medical devices and equipment companies - an important growth sector for this…

LWI: The novel Web-based international trading portal

LifeWorld International Inc (LWI), the internet portal for bilateral global trade in science products and technology transfer of healthcare equipment, pharmaceuticals, chemistry and computer technology, enables public and private sector buyers to obtain the products and services they need while offering reputable and pre-qualified sellers to present their products in reverse online auctions.

Photo

Xarelto gains EU approval

The European Commission has granted marketing approval to the Bayer Group for Xarelto (rivaroxaban), an anticoagulant taken as one tablet, once-daily, to prevent venous thrombo-embolic events (VTE) in adults undergoing elective (planned) hip or knee replacement surgery.

113 show more articles
Subscribe to Newsletter